July 24th 2023
Shared insight on the evolving state of renal cell carcinoma management and hope for future growth in the treatment landscape.
Focusing their discussion on a real-world patient scenario, expert panelists discuss treatment options in the setting of advanced non-clear cell renal cell carcinoma.
July 17th 2023
Switching their focus to relapsed/refractory advanced clear cell renal cell carcinoma, key opinion leaders review treatment options in this setting.
Comprehensive insight to treatment options available in the second-line setting of advanced clear cell renal cell carcinoma.
July 10th 2023
Focused discussion on the rationale behind discontinuing (or continuing) immunotherapy for patients with advanced clear cell renal cell carcinoma.
Centering discussion on a patient scenario of advanced clear cell renal cell carcinoma, panelists reflect on how they would approach selecting first-line therapy.
July 3rd 2023
Panelists consider best practices in dosing while managing patients on first-line therapy for advanced clear cell renal cell carcinoma.
Expert perspectives on the adverse event profiles of first-line combination therapies in the advanced clear cell renal cell carcinoma space.
June 26th 2023
A brief discussion on the patient and disease characteristics that help to inform selection of best therapy for patients with advanced clear cell renal cell carcinoma.
Key opinion leaders on renal cell carcinoma management review first-line treatment options in the advanced clear cell disease space.